melanoma
aggress
form
skin
cancer
respons
major
skin
cancer
relat
death
thu
search
natur
molecul
effect
destroy
tumor
promot
immun
activ
essenti
design
novel
therapi
metastat
melanoma
report
first
time
natur
triterpenoid
ganoder
acid
dm
gadm
induc
orchestr
autophag
apoptot
cell
death
well
enhanc
immunolog
respons
via
increas
hla
class
ii
present
melanoma
cell
annexin
v
stain
flow
cytometri
show
gadm
treatment
induc
apoptosi
melanoma
cell
support
detect
increas
bax
protein
coloc
elev
cytochrom
c
subsequ
cleavag
caspas
furthermor
gadm
treatment
initi
possibl
crosstalk
autophagi
apoptosi
evidenc
increas
level
protein
time
interplay
apoptot
andor
antiapoptot
molecul
melanoma
cell
despit
gadm
moder
cytotox
viabl
cell
express
high
level
hla
class
ii
protein
improv
antigen
present
cell
recognit
antitumor
efficaci
gadm
also
investig
vivo
murin
melanoma
model
gadm
treatment
slow
tumor
format
signific
reduct
tumor
volum
taken
togeth
find
demonstr
potenti
gadm
natur
chemoimmunotherapeut
capabl
induc
possibl
crosstalk
autophagi
apoptosi
well
improv
immun
recognit
sustain
melanoma
tumor
clearanc
melanoma
aggress
form
skin
cancer
everincreas
preval
western
world
among
human
tumor
melanoma
one
poorest
prognosi
mean
surviv
year
patient
unresect
distant
metastas
patient
metastat
melanoma
year
surviv
mean
month
lessinvas
treatment
option
melanoma
includ
radiat
chemotherapi
immunotherapi
prove
rather
ineffect
treat
diseas
standard
therapi
also
fail
show
meaning
impact
surviv
patient
show
posit
initi
respons
rapid
deterior
often
ensu
except
recent
discov
monoclon
antibodi
ipilimumab
shown
signific
surviv
benefitin
metastat
melanoma
past
three
decad
incid
melanoma
increas
rapidli
solid
malign
sixth
commonli
diagnos
malign
unit
state
steadi
increas
incid
melanoma
result
dire
need
rel
lowcost
therapi
greater
efficaci
despit
toxic
chemotherapeut
drug
becom
gener
mainstay
cancer
treatment
destroy
cancer
cell
induc
apoptosi
effect
reduc
size
tumor
prevent
tumor
growth
anoth
less
welldefin
surviv
pathway
druginduc
cell
death
autophagi
process
within
cell
util
lysosom
machineri
sequest
degrad
molecul
autophagi
crucial
recycl
cellular
compon
gener
nutrient
enabl
surviv
time
cellular
stress
howev
excess
autophagi
may
lead
cell
death
follow
hallmark
typic
apoptot
event
apoptosi
autophagi
distinct
cellular
process
distinguish
molecular
mediat
nevertheless
could
crosstalk
two
pathway
may
regul
cell
deathsurviv
pathway
particular
cellular
condit
understand
delic
balanc
might
help
investig
design
new
anticanc
therapeut
modul
cellular
process
reduc
tumor
burden
consid
fact
immun
evas
essenti
tumor
develop
standard
chemotherapi
drawback
treatmentassoci
toxic
becom
crucial
search
natur
therapeut
less
cytotox
normal
cell
enhanc
immun
respons
one
attract
sourc
antitumor
product
ganoderma
lucidum
mushroom
use
centuri
herbal
medicin
prevent
treatment
varieti
inflammatori
malign
diseas
crude
extract
ganoderma
lucidum
mushroom
shown
caus
cytotox
tumor
cell
line
triterpenoid
extract
ganoderma
ganoder
acid
dm
gadm
never
test
antitumor
activ
human
melanoma
cell
major
human
melanoma
cell
express
hla
class
ii
molecul
bind
peptid
gener
degrad
exogen
endogen
antigen
present
class
iipeptid
complex
cell
immun
recognit
intracellular
protein
tumor
fragment
may
get
access
vacuolar
compart
sequestr
doublemembran
organel
autophagosom
fuse
vesicl
endolysosom
compart
antigen
process
peptid
load
onto
hla
class
ii
protein
take
place
recent
studi
suggest
cellular
autophag
activ
could
give
rise
hla
class
ii
ligand
cell
recognit
thu
current
studi
also
investig
whether
natur
product
gadm
could
influenc
intracellular
machineri
melanoma
cell
hla
class
ii
process
present
cell
immun
recognit
report
gadm
treatment
induc
autophag
apoptot
event
well
immun
activ
human
melanoma
cell
may
import
regul
cancer
develop
progress
determin
respons
tumor
cell
anticanc
therapi
also
show
gadm
treatment
reduc
tumor
burden
vivo
mous
melanoma
model
current
find
highlight
potenti
gadm
natur
chemoimmunotherapeut
capabl
induc
tumor
destruct
also
activ
possibl
immun
respons
imper
sustain
melanoma
tumor
remiss
human
melanoma
cell
line
maintain
complet
invitrogen
grand
island
ny
medium
supplement
fetal
bovin
serum
fb
hyclon
logan
ut
uml
penicillin
streptomycin
mediatech
inc
manassa
va
lglutamin
mediatech
cell
constitut
express
molecul
cell
surfac
human
melanoma
cell
line
maintain
complet
imdm
heatinactiv
bovin
growth
serum
bg
hyclon
uml
penicillin
streptomycin
lglutamin
cell
transduc
use
retrovir
vector
constitut
express
link
drug
select
marker
hygromycin
histidinol
resist
express
surfac
complex
cell
confirm
flow
cytometr
analysi
use
mab
mous
melanoma
cell
line
gift
dr
mark
rubinstein
medic
univers
south
carolina
charlerston
cultur
complet
rpmi
supplement
hepe
nonessenti
amino
acid
invitrogen
describ
human
serum
albumin
hsa
purchas
sigmaaldrich
st
loui
mo
human
hsa
peptid
vklvnevtefaktk
produc
use
fmoc
technolog
appli
biosystem
synthes
describ
peptid
puriti
sequenc
analyz
revers
phase
hplc
purif
mass
spectroscopi
peptid
dissolv
dmso
store
use
primari
antibodi
use
human
caspas
alexi
biochem
plymouth
meet
pa
caspas
cytochrom
c
cell
signal
technolog
danver
bax
survivin
hladm
hladr
santa
cruz
biotechnolog
inc
santa
cruz
ca
clone
sigma
st
loui
mo
hla
class
ii
invari
chain
ii
pin
antibodi
obtain
dr
janic
blum
indiana
univers
school
medicin
indianapoli
secondari
antibodi
use
horseradish
peroxidas
conjug
antimous
pierc
rockford
il
usa
antirabbit
antigoat
igg
santa
cruz
ganoder
acid
dm
gadm
origin
isol
ganoderma
lucidum
mushroom
purchas
planta
analytica
llc
danburi
ct
cat
puriti
gadm
determin
vendor
use
lcm
analysi
gadm
dissolv
dmso
sigma
make
mm
stock
solut
use
cytotox
assay
gadm
treatment
dmso
final
concentr
melanoma
cell
line
seed
cellswel
appropri
cultur
medium
flatbottom
plate
gadm
ad
appropri
well
final
concentr
h
cell
also
treat
gadm
h
presenc
absenc
autophagi
inhibitor
sigma
pan
caspas
inhibitor
zvadfmk
r
system
minneapoli
mn
overnight
follow
treatment
cell
viabil
measur
use
celltit
aqueou
one
solut
cell
prolifer
assay
mt
promega
madison
wi
twenti
mt
reagent
ad
well
plate
incub
h
incub
absorb
read
nm
cell
treat
vehicl
alon
use
control
percent
cell
death
induc
gadm
calcul
use
equat
absorb
control
absorb
treat
absorb
control
experi
repeat
least
three
time
data
express
percent
cytotox
sd
triplic
well
hoechst
stain
dna
fragment
assay
cell
ml
treat
vehicl
dmso
alon
gadm
tissu
cultur
plate
corn
h
cell
incub
hoechst
stain
sigma
aldrich
minut
examin
fluoresc
microscop
axiovert
ultraviolet
filter
carl
zeiss
jena
germani
magnif
dna
fragment
assay
cell
treat
vehicl
alon
gadm
h
cell
sampl
treat
known
apoptosi
induc
staurosporin
use
posit
control
dna
fragment
extract
use
dna
gentra
puregen
cell
kit
qiagen
describ
manufactur
protocol
dna
sampl
contain
dna
mixedwith
load
dye
sigma
analyz
agaros
gel
sigma
electrophoresi
prestain
mmoll
ethidium
bromid
sigma
gel
electrophoresi
includ
dna
marker
bp
melanoma
cell
treat
vehicl
alon
gadm
h
wash
dulbecco
phosphatebuff
salin
dpb
fraction
describ
previous
briefli
cell
resuspend
ice
cold
buffer
mm
hepe
ph
mm
edta
mm
egta
mm
dithiothreitol
proteas
inhibitor
cocktail
gentl
pipet
kept
ice
min
follow
addit
vigor
vortex
second
sampl
first
spun
rpm
min
supernat
collect
spun
rpm
min
supernat
obtain
use
cytoplasm
fraction
subject
western
blot
analysi
detect
cytochrom
c
protein
cell
cultur
h
presenc
vehicl
alon
gadm
follow
treatment
cell
wash
cell
lysat
obtain
use
standard
lysi
buffer
mm
trizma
base
mm
nacl
tritonx
equal
protein
concentr
design
cell
lysat
separ
bistri
nupag
gel
invitrogen
grand
island
ny
protein
transfer
onto
nitrocellulos
membran
pierc
rockford
il
probe
antibodi
express
caspas
cytochrom
c
survivin
bax
hla
class
ii
hladr
hladm
invari
chain
ii
protein
secondari
antibodi
use
horseradish
peroxidas
conjug
antimous
pierc
antirabbit
antigoat
igg
santa
cruz
biotechnolog
monoclon
antibodi
use
protein
load
control
analyz
caspas
activ
melanoma
cell
treat
gadm
presenc
absenc
pancaspas
inhibitor
zvadfmk
r
system
minneapoli
mn
final
concentr
cell
incub
h
cell
viabil
measur
use
mt
assay
describ
cell
cultur
h
presenc
vehicl
alon
gadm
follow
treatment
cell
wash
stain
buffer
heatinactiv
bg
hyclon
resuspend
bind
buffer
cat
bd
bioscienc
hepe
ph
nacl
mm
cacl
cell
stain
annexin
vfitc
cat
bd
bioscienc
follow
addit
propidium
iodid
pi
cat
bd
bioscienc
sampl
analyz
facscan
use
cellquest
softwar
bd
bioscienc
mountain
view
ca
apoptot
cell
examin
mitochondri
dysfunct
cell
treat
vehicl
alon
gadm
also
stain
tmre
tetramethylrhodamin
ethyl
ester
nm
sigma
analyz
flow
cytometri
accord
manufactur
protocol
cell
cultur
glass
coverslip
cat
fisher
scientif
co
presenc
vehicl
alon
gadm
h
cell
wash
fix
acetonemethanol
mixtur
min
room
temperatur
nonadher
cell
collect
well
plate
contain
coverslip
centrifug
min
fix
ident
adher
cell
cell
permeabil
triton
min
block
normal
serum
min
incub
cytochrom
c
antibodi
c
h
follow
incub
cell
wash
twice
bsa
cat
omnipur
emd
cincinnati
oh
pb
incub
alexa
conjug
donkey
antigoat
ig
santa
cruz
alexa
conjug
goat
antimous
ig
santa
cruz
h
cell
also
counterstain
dapi
nuclear
local
slide
mount
fluoresc
mount
medium
g
south
biotechnolog
inc
observ
oil
immers
object
len
analyz
leica
tc
confoc
laser
scan
microscop
use
lasaf
softwar
leica
lasertechnik
cell
cellsml
treat
either
vehicl
alon
gadm
h
c
cultur
media
plate
cat
corn
incorpor
hsa
peptid
ad
appropri
well
last
h
incub
describ
cell
also
treat
autophagi
inhibitor
pan
caspas
inhibitor
zvadfmk
h
follow
addit
hsa
peptid
overnight
cell
wash
cocultur
hsa
peptid
specif
cell
hybridoma
h
follow
incub
plate
store
c
test
product
cell
product
measur
enzymelink
immunosorb
assay
elisa
accord
manufactur
instruct
r
system
minneapoli
mn
usa
purchas
sigmaaldrich
assay
repeat
least
three
time
tumor
induc
subcutan
inject
cell
cell
viabil
trypan
blue
exclus
right
flank
mice
treatment
initi
ip
inject
gadm
mgkg
control
vehicl
dmso
day
day
implant
follow
treatment
tumor
volum
determin
period
interv
use
digit
calip
measur
longest
diamet
next
longest
diamet
b
perpendicular
use
measur
tumor
volum
calcul
formula
vab
mice
kept
observ
tumor
volum
determin
mm
point
requisit
euthan
owe
size
tumor
experi
tumor
tissu
obtain
gadm
mgkg
vehicleonli
treat
mice
day
melanoma
implant
analyz
immunohistochemistri
cell
infiltr
tumor
sampl
first
fix
formalin
embed
paraffin
stain
antibodi
holl
cancer
center
immunohistochemistri
facil
treatment
control
group
consist
mice
data
shown
repres
least
three
separ
experi
work
mice
approv
medic
univers
south
carolina
anim
protocol
review
board
perform
accord
nation
institut
health
guid
care
use
laboratori
anim
data
experiment
group
subject
statist
analysi
anova
posthoc
test
repeat
measur
anova
posthoc
test
student
ttest
use
appropri
twosid
test
use
case
p
valu
consid
statist
signific
initi
screen
gadm
anticanc
effect
carri
four
human
melanoma
cell
line
cell
simultan
treat
vehicl
alon
dmso
serial
dose
gadm
detriment
effect
measur
mt
assay
describ
method
result
show
gadm
reduc
viabil
test
melanoma
cell
dosedepend
manner
mean
ic
fig
time
cours
studi
h
treatment
also
perform
use
gadm
two
melanoma
cell
line
supplement
fig
data
show
earli
time
point
h
gadm
concentr
effect
kill
melanoma
cell
supplement
fig
b
later
time
point
h
gadm
induc
detect
cell
death
gadm
effect
induc
cytotox
cell
line
supplement
fig
detect
apoptot
chang
induc
gadm
melanoma
cell
incub
min
hoechst
dye
commonli
use
stain
genom
dna
hoechst
stain
cell
show
gadm
treatment
induc
apoptot
event
characterist
chromatin
condens
microscop
observ
fig
demonstr
typic
morpholog
apoptot
nuclei
stain
hoechst
chromatin
condens
aggreg
nuclear
membran
indic
bright
fluoresc
peripheri
also
dna
fragment
assay
show
gadm
treatment
induc
internucleosom
dna
fragment
cell
fig
known
apoptosi
induc
staurosporin
use
posit
control
also
show
internucleosom
dna
fragment
gel
thu
chromatin
condens
detect
fig
may
consequ
dna
cleavag
within
die
cell
analysi
cell
cycl
progress
suggest
gadm
treatment
caus
arrest
melanoma
cell
supplement
fig
gadm
treatment
also
induc
dosedepend
antiprolif
activ
induc
apoptot
event
mous
melanoma
cell
supplement
fig
data
shown
investig
gadminduc
apoptot
pathway
melanoma
cell
examin
underli
molecular
mechan
antitumor
effect
western
blot
analysi
whole
cell
lysat
show
gadm
treatment
induc
concurr
surg
activ
form
caspas
protein
cell
suggest
role
caspas
execut
melanoma
cell
death
caspas
activ
indic
cleavag
procaspas
number
catalyt
subunit
fig
order
test
whether
vitro
caspas
inhibit
could
revers
cytotox
use
pancaspas
inhibitor
zvadfmk
known
bind
catalyt
site
activ
caspas
render
inact
briefli
cell
treat
gadm
presenc
absenc
zvadfmk
h
fig
data
show
inhibit
caspas
zvadfmk
earli
time
point
h
alter
gadminduc
cell
death
howev
later
time
point
h
inhibit
caspas
significantli
revers
cell
death
cell
line
data
suggest
gadm
treatment
may
initi
timedepend
process
activ
cell
surviv
apoptot
protein
melanoma
cell
determin
molecular
mechan
underli
regul
gadm
initi
apoptosi
analyz
cellular
express
famili
protein
bax
inhibitor
apoptosi
protein
survivin
western
blot
analysi
show
gadm
treatment
reduc
survivin
protein
express
upregul
express
level
bax
protein
whole
cell
lysat
cell
fig
b
signific
chang
protein
express
detect
cell
fig
b
meanwhil
gadm
treatment
caus
signific
increas
apoptot
cytochrom
c
cytosol
fraction
cell
along
induct
fig
disturb
ratio
suggest
role
gadm
induc
mitochondri
dysfunct
increas
cytosol
cytochrom
c
melanoma
cell
experi
use
tmre
stain
melanoma
cell
confirm
gadm
treatment
caus
signific
loss
mitochondri
membran
potenti
preced
cytochrom
c
releas
fig
releas
cytochrom
c
may
also
subsequ
promot
oligomer
presenc
caspas
could
form
larg
multimer
apoptosom
activ
downstream
caspas
cascad
immunofluoresc
studi
confirm
remark
upregul
coloc
cytochrom
c
green
red
protein
cytoplasm
gadmtreat
melanoma
cell
impli
apoptosom
format
trigger
cellular
apoptosi
furthermor
flow
cytometr
analysi
annexin
v
propidium
iodidestain
melanoma
cell
show
measur
increas
level
apoptot
event
develop
gadmtreat
cell
compar
treat
vehicl
alon
appar
earli
late
apoptot
event
promin
cell
treat
gadm
h
gate
control
treat
cell
taken
togeth
data
indic
gadm
treatment
activ
intrins
pathway
apoptosi
caspas
process
play
key
role
melanoma
cell
death
depend
type
stimulu
autophagi
function
cell
surviv
cell
death
mechan
evalu
role
gadm
induct
autophagi
conduct
posttreat
timelin
western
blot
analyz
chang
autophag
protein
long
identifi
partner
result
show
signific
increas
protein
express
h
gadm
treatment
drastic
declin
h
treatment
figur
b
data
indic
possibl
bind
surviv
protein
trigger
apoptot
event
character
activ
caspas
also
monitor
gadmtreat
cell
anoth
autophag
protein
marker
autophagosom
format
result
show
gadm
treatment
induc
timedepend
activ
protein
reach
peak
h
posttreat
suggest
treat
melanoma
cell
underw
autophagi
possibl
surviv
mechan
fig
b
concurr
timelin
cytototox
assay
presenc
absenc
autophagi
inhibitor
show
block
autophag
event
rel
earlier
time
point
h
induc
cell
death
fig
contrast
remark
cell
execut
occur
beyond
h
treatment
regardless
treatment
fig
indic
excess
autophagi
may
trigger
subsequ
caspas
depend
apoptot
pathway
taken
togeth
data
suggest
potenti
autophagi
apoptosi
crosstalk
possibl
mechan
action
effect
antitumor
respons
exploit
melanoma
therapi
studi
suggest
autophag
activ
facilit
antigen
process
present
via
hla
molecul
critic
develop
immun
malign
tumor
order
evalu
whether
gadminduc
autophagi
melanoma
cell
influenc
intracellular
hla
class
ii
protein
present
cell
cell
subject
western
blot
function
antigen
present
assay
data
show
signific
upregul
hla
class
ii
molecul
well
lysosom
protein
gadmtreat
melanoma
cell
fig
correl
earli
autophag
event
evidenc
express
cell
analysi
hla
class
ii
compon
western
blot
show
signific
increas
hladr
hladm
protein
differenti
ii
express
fig
b
indic
activ
hla
class
ii
antigen
process
machineri
gadmtreat
melanoma
cell
howev
signific
chang
heat
shock
protein
gadmtreat
cell
observ
analyz
western
blot
data
shown
indic
chaperonemedi
autophagi
may
involv
cellular
stress
rather
macroautophagi
play
role
hla
class
ii
activ
cellmedi
immun
activ
recognit
gadmtreat
melanoma
cell
also
examin
vitro
use
whole
hsa
protein
hsa
peptid
model
studi
antigen
process
present
specif
cell
result
show
gadm
treatment
increas
hla
class
ii
antigen
present
cell
recognit
melanoma
tumor
cell
fig
also
observ
gadm
enhanc
hsa
process
present
via
hla
class
ii
protein
although
declin
antigen
present
observ
treatment
higher
dose
gadm
data
shown
unexpect
higher
dose
gadm
induc
signific
cytotox
cell
death
howev
remain
viabl
tumor
cell
remain
capabl
induc
cell
respons
studi
whether
block
autophagi
alter
cell
recognit
melanoma
cell
cell
treat
either
vehicl
alon
gadm
autophagi
inhibitor
data
show
block
autophagi
reduc
cell
respons
antigen
present
gadmtreat
cell
supplement
fig
result
also
show
pan
caspas
inhibitor
zvadfmk
treatment
restor
express
supplement
fig
well
antigen
present
cell
recognit
gadm
treat
cell
supplement
fig
order
assess
vivo
antitumor
efficaci
gadm
use
murin
melanoma
model
describ
previous
mice
inject
ip
gadm
mgkg
control
vehicl
day
follow
subcutan
implant
melanoma
tumor
cell
describ
data
show
gadm
treatment
reduc
normal
growth
tumor
fig
result
signific
diminut
tumor
volum
treat
mice
last
three
week
tumor
implant
fig
day
treat
mice
still
possess
reduc
tumor
volum
least
day
compar
untreat
mice
supplement
fig
data
also
show
mice
develop
tumor
gadmtreat
mice
develop
smaller
tumor
overal
immunohistochem
analysi
stain
confirm
host
cell
infiltr
greater
extent
tumor
tissu
treat
mice
treat
vehicl
alon
fig
c
find
suggest
gadm
may
serv
potenti
chemoand
immunotherapeut
natur
product
attenu
melanoma
growth
vivo
defin
featur
convent
anticanc
therapi
capac
evok
cellular
death
induc
cell
apoptosi
howev
inher
acquir
resist
cancer
cell
chemotherapi
major
obstacl
complet
treatment
suffici
prevent
tumor
reoccurr
therefor
search
new
natur
drug
sensit
cancer
cell
chemotherapymedi
apoptosi
also
restor
antitumor
immun
increasingli
becom
focu
investig
recent
exploit
mechan
autophagi
emerg
potenti
strategi
induc
tumor
cell
death
studi
shown
gadm
natur
product
medicin
mushroom
ganoderma
lucidum
inhibit
prolifer
kill
human
metastat
melanoma
low
micromolar
concentr
also
significantli
restor
immun
recognit
tumor
cell
also
provid
evid
gadm
induc
orchestr
molecular
crosstalk
earli
autophagi
may
contribut
apoptot
cell
death
data
indic
h
gadm
treatment
melanoma
cell
result
typic
apoptot
event
degrad
dna
distinguish
subsequ
cleavag
chromatin
dna
internucleosom
fragment
observ
hoechst
stain
dna
fragment
assay
treat
melanoma
apoptot
cell
death
carri
upregul
cleavag
initi
caspas
execution
caspas
biochem
analysi
show
caspas
protein
express
correl
surg
cellular
caspas
catalyt
activ
markedli
diminish
pan
caspas
inhibitor
zvadfmk
indic
key
role
caspas
execut
gadmtreat
melanoma
mechanist
investig
melanoma
cell
death
reveal
gadm
treatment
induc
express
proapoptot
bax
mark
suppress
prosurviv
protein
survivin
destabil
mitochondri
membran
potenti
analysi
cytoplasm
fraction
treat
cell
detect
remark
elev
apoptot
protein
also
coloc
cytochrom
c
melanoma
cell
suggest
involv
intrins
apoptot
pathway
cellular
insult
start
migrat
bax
surfac
mitochondria
subsequ
inhibit
protect
effect
mediat
releas
cytochrom
c
suggest
previous
cytochrom
c
complex
form
apoptosom
activ
caspas
trigger
effector
caspas
cascad
lead
induct
apoptosi
melanoma
cell
describ
annexin
v
stain
treat
melanoma
cell
support
notion
signific
portion
gadmtreat
cell
undergo
apoptosi
includ
earli
late
apoptot
event
autophagi
function
cell
surviv
cell
death
mechan
depend
context
stimuli
like
exploit
cancer
therapi
timedepend
cell
death
treat
melanoma
suggest
appar
role
gadm
promot
toxic
form
autophagi
possibl
contribut
activ
intrins
apoptosi
pathway
protein
analysi
melanoma
cell
show
earli
event
h
follow
gadm
treatment
featur
signific
upregul
autophagi
regulatori
protein
yet
autophag
marker
especi
drastic
reduc
later
time
point
h
suggest
shift
apoptosi
autophagi
protein
long
identifi
partner
thu
data
suggest
earli
increas
treat
melanoma
cell
may
contribut
interplay
apoptot
surviv
protein
deactiv
mitochondri
protect
trigger
intrins
apoptot
event
although
current
chemotherapi
melanoma
shown
high
success
rate
earli
stage
diseas
fail
reliev
suffer
late
stage
metastat
diseas
thu
treatment
strategi
adopt
combin
chemotherapi
immunotherapi
destroy
cancer
cell
well
elev
antitumor
immun
prevent
reoccurr
unfortun
mani
clinic
trial
immunotherapi
prove
advantag
current
chemotherapi
strategi
suggest
promin
defect
tumor
cellexpress
immun
compon
prerequisit
cell
stimul
via
cellmedi
immun
pathway
thu
agent
could
enhanc
tumor
immunogen
reduc
tumor
burden
would
ideal
chemoimmunotherapeut
overcom
major
constraint
bound
melanoma
treatment
key
aspect
immun
respons
tumor
cell
observ
amplif
hla
class
iimedi
antigen
present
cell
data
clearli
show
gadm
treatment
capabl
augment
hlaclass
ii
pathway
immun
recognit
increas
level
gadm
may
also
complement
cell
recognit
via
endolysosom
class
ii
pathway
block
autophagi
may
reduc
immun
recognit
tumor
cell
suboptim
kill
tumor
may
enhanc
immun
recognit
via
hla
class
ii
pathway
despit
fact
dose
gadm
higher
induc
cytotox
melanoma
cell
h
treatment
remain
viabl
cell
abl
present
antigen
stimul
cell
evid
lower
concentr
gadm
show
much
stronger
effect
induc
immun
respons
surviv
cell
capabl
process
whole
antigen
present
cell
antitumor
effect
gadm
slower
growth
host
cell
infiltr
tumor
mass
also
observ
vivo
mous
melanoma
model
suggest
potenti
gadm
complementari
chemotherapeut
malign
tumor
futur
studi
underway
determin
molecular
mechan
vivo
therapeut
effect
gadm
treatment
current
find
suggest
enorm
potenti
gadm
chemoimmunotherapeut
agent
treat
malign
diseas
refer
web
version
pubm
central
supplementari
materi
cell
treat
vehicl
alon
gadm
h
presenc
absenc
zvadfmk
follow
mt
viabil
assay
describ
experi
repeat
least
three
time
data
express
mean
sd
signific
differ
calcul
student
test
p
fig
use
refer
quantit
rel
express
protein
control
gadm
treat
cell
signific
differ
control
calcul
student
test
p
ns
signific
c
antigen
present
assay
show
improv
antigen
present
cell
recognit
three
differ
melanoma
cell
treat
gadm
cell
transduc
molecul
describ
cell
innat
express
cell
surfac
protein
cell
treat
vehicl
alon
gadm
h
plate
follow
addit
hsa
peptid
anoth
h
cell
wash
cocultur
peptid
specif
cell
hybridoma
h
product
measur
elisa
express
pgml
sd
triplic
well
least
three
independ
experi
p
